1. Home
  2. BFRG vs TCRT Comparison

BFRG vs TCRT Comparison

Compare BFRG & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bullfrog AI Holdings Inc.

BFRG

Bullfrog AI Holdings Inc.

SELL

Current Price

$0.37

Market Cap

8.6M

Sector

Technology

ML Signal

SELL

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

SELL

Current Price

$1.71

Market Cap

7.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
BFRG
TCRT
Founded
2017
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.6M
7.8M
IPO Year
2022
2025

Fundamental Metrics

Financial Performance
Metric
BFRG
TCRT
Price
$0.37
$1.71
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
148.1K
★ 290.2K
Earning Date
11-13-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 25.88
24.66
EPS
★ N/A
N/A
Revenue
$116,670.00
★ $15,900,000.00
Revenue This Year
$568.55
N/A
Revenue Next Year
$573.08
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 79.49
N/A
52 Week Low
$0.39
$0.72
52 Week High
$1.96
$4.50

Technical Indicators

Market Signals
Indicator
BFRG
TCRT
Relative Strength Index (RSI) 31.50 47.70
Support Level N/A $1.61
Resistance Level $0.69 $1.82
Average True Range (ATR) 0.05 0.14
MACD -0.02 -0.03
Stochastic Oscillator 2.00 47.44

Price Performance

Historical Comparison
BFRG
TCRT

About BFRG Bullfrog AI Holdings Inc.

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. The Company is focused specifically on advance artificial intelligence and machine learning (AI/ML)- driven analysis of complex datasets in medicine and healthcare. The Company's objective is to use its AI/ML platform to provide a precision-medicine approach to drug-asset enablement through external partnerships and selective internal development.

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

Share on Social Networks: